World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 June 2021
Main ID:  NCT04902560
Date of registration: 18/05/2021
Prospective Registration: Yes
Primary sponsor: University Hospital, Montpellier
Public title: Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study GONOCEF
Scientific title: Overall Patient Care in a Montpelier Sexual Health Center (CeGIDD). Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study
Date of first enrolment: May 1, 2021
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT04902560
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
France
Contacts
Name:     Dorian Belakebi, resident
Address: 
Telephone: 06.58.30.08.36
Email: d-belakebi@chu-montpellier.fr
Affiliation: 
Name:     Eric Picot, PhD
Address: 
Telephone: 06.07.57.26.62
Email: e-picot@chu-montpellier.fr
Affiliation: 
Name:     Du Thanh Aurelie
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Montpellier
Key inclusion & exclusion criteria

Inclusion criteria:

- Aged more than 18 years old

- Non-opposition form given to the subject

- Having at least one exam positive for Gonorrhoea (PCR or Culture), realised in CeGIDD
de Montpellier

Exclusion criteria:

- patient's refusal to participate



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Gonorrhea
Intervention(s)
Primary Outcome(s)
Response rate to Ceftriaxone 1g IM in Gonorrhoea. [Time Frame: day 1]
Secondary Outcome(s)
Adverse drug reaction rates [Time Frame: day 1]
Concordance rate with positive PCR [Time Frame: day 1]
Rate of realized TOC [Time Frame: day 1]
Rate of time before realizing the TOC. [Time Frame: day 1]
Rate of untreated patient despite having a positive test for gonorrhea (lost to follow-up) [Time Frame: day 1]
Resistance rate to ceftriaxone and AMR description. [Time Frame: day 1]
Secondary ID(s)
RECHMPL21_0301
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history